Strong trader consensus against a new pandemic emerging in 2026 reflects the absence of any pathogen achieving sustained global human-to-human transmission or meeting WHO criteria for a pandemic emergency, despite the ongoing Bundibugyo virus Ebola outbreak declared a public health emergency of international concern in May. This regional event in the DRC and Uganda, with thousands of cases but limited spread beyond borders and very low risk to Europe or the Americas per ECDC and CDC assessments, aligns with historical Ebola patterns of localized hemorrhagic fever transmission requiring direct contact. Ongoing surveillance by WHO, Africa CDC, and national agencies shows no evidence of exponential global growth or novel respiratory strains with pandemic potential, though uncertainties remain around underreporting, possible mutation, or an undetected Disease X spillover before year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$1,057,636 Vol.
$1,057,636 Vol.
$1,057,636 Vol.
$1,057,636 Vol.
The resolution source will be official announcements from the World Health Organization.
Market Opened: Dec 1, 2025, 4:37 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Strong trader consensus against a new pandemic emerging in 2026 reflects the absence of any pathogen achieving sustained global human-to-human transmission or meeting WHO criteria for a pandemic emergency, despite the ongoing Bundibugyo virus Ebola outbreak declared a public health emergency of international concern in May. This regional event in the DRC and Uganda, with thousands of cases but limited spread beyond borders and very low risk to Europe or the Americas per ECDC and CDC assessments, aligns with historical Ebola patterns of localized hemorrhagic fever transmission requiring direct contact. Ongoing surveillance by WHO, Africa CDC, and national agencies shows no evidence of exponential global growth or novel respiratory strains with pandemic potential, though uncertainties remain around underreporting, possible mutation, or an undetected Disease X spillover before year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions